• English
  • 简体中文
Login Register
Current Location: Home > Global Clinical Trial Registry Feedback Help
-
Export
Public title Primary sponsor Recruitment status Phase Date of registration Health Condition(s)
IBCSG 14-93 - Adjuvant therapy for post/peri menopausal patients with node positive breast cancer who are not suitable for endocrine therapy alone Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-05-27 Breast Cancer
ANZ 8614: A phase III randomised trial of mitozantrone versus CMFP (cyclophosphamide, methotrexate, 5-flourouracil, prednisone) in advanced breast cancer – a quality of life study Other Collaborative groups Australian New Zealand Breast Cancer Trials Group (ANZ BCTG) Phase 3 1994-10-25 Advanced breast cancer
IBCSG VII - Adjuvant chemotherapy in node positive postmenopausal breast cancer patients: endocrine vs. chemo-endocrine vs. chemo-endocrine with delayed chemotherapy. Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-11-03 Breast Cancer
IBCSG IX - Adjuvant therapy in postmenopausal patients with node negative breast cancer Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-11-03 Breast Cancer
IBCSG 13-93 - Adjuvant therapy for premenopausal patients with node positive breast cancer who are not suitable for endocrine therapy alone Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-11-03 Breast Cancer
ANZ 8811: A Phase III study to compare the effect of Zoladex depot (ICI 118,630) with Nolvadex plus Zoladex depot in pre- and peri-menopausal patients with advanced breast cancer. Other Collaborative groups Australian New Zealand Breast Cancer Trials Group (ANZ BCTG) Phase 3 1994-11-03 Advanced breast cancer
IBCSG VI - Adjuvant therapy in node positive pre/perimenopausal breast cancer patients: CMF 3 vs. 6 with or without reintroduction of chemotherapy. Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-11-03 Breast Cancer
IBCSG 11-93 - Adjuvant therapy for premenopausal patients with node positive breast cancer who are suitable for endocrine therapy alone Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-11-03 Breast Cancer
IBCSG VIII - Adjuvant therapy in pre- and peri-menopausal patients with node negative breast cancer Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-11-03 Breast Cancer
IBCSG 12-93 - Adjuvant therapy for post/perimenopausal patients with node positive breast cancer who have oestrogen receptor positive tumours Other Collaborative groups International Breast Cancer Study Group Phase 3 1994-11-03 Breast Cancer
ANZ 8613: A Phase III trial to evaluate additional versus substitution endocrine therapy in advanced breast cancer Other Collaborative groups Australian New Zealand Breast Cancer Trials Group (ANZ BCTG) Phase 3 1994-11-29 Advanced breast cancer
Does the addition of tamoxifen to standard chemotherapy improve the time to progression of disease in women with advanced ovarian cancer? Charities/Societies/Foundations The Cancer Council Victoria Phase 3 1994-12-09 Advanced carcinoma of the ovary
A randomised trial investigating the effectiveness of different durations of maximal androgen deprivation prior to and during definitive radiation therapy for locally advanced carcinoma of the prostate Other Collaborative groups Trans Tasman Radiation Oncology Group (TROG) Phase 3 1995-12-18 Prostate Cancer
IBCSG 15-95 - Randomised trial of high-dose epirubicin and cyclophosphamide x 3 supported by peripheral blood progenitor cells versus anthracycline and cyclophosphamide x 4 followed by cyclophosphamide, methotrexate, and 5-fluoruracil x 3 as adjuvant trea Other Collaborative groups International Breast Cancer Study Group Phase 3 1996-06-01 Breast Cancer
Protocol for the management of screen detected ductal carcinoma in situ (DCIS) of the breast Other Collaborative groups Australia and New Zealand Breast Cancer Trials Group Ltd Phase 3 1996-07-10 Breast Cancer
Intergroup Exemestane Study (IES) Commercial sector/Industry Pharmacia and Upjohn (now merged as part of Pfizer) Phase 3 1998-03-20 Breast Cancer
ATAC - Arimidex, Tamoxifen, Alone or in Combination Commercial sector/Industry AstraZeneca (formerly known as Zeneca, formerly known as ICI) Phase 3 1998-03-20 Breast Cancer
Adjuvant Treatment for patients with node-positive Breast Cancer Docetaxel sequentially or in combination with Doxorubicin, followed by CMF (cyclophosphamide, methotrexate, fluorouracil) vs. Doxorubicin alone or in combination with Cyclophosphamide, follo Commercial sector/Industry sanofi-aventis Talavera Corporate Centre Building D 12-24 Talavera Road Macquarie Park, NSW 2113 Phase 3 1999-05-12 Breast Cancer
IBCSG 10-93 - Surgical therapy with or without axillary node clearance for breast cancer in the elderly who receive adjuvant therapy with Tamoxifen Other Collaborative groups International Breast Cancer Study Group Phase 3 1999-05-12 Breast Cancer
"Clinical Trials to Enhance Elders' Oral Health" ("TEETH") University of Washington Completed Phase 3 1999-09-17 Tooth Loss;Periodontal Disease;Tooth Decay